Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RU-101 in Severe Dry Eye
NCT01843894Phase 2Completed
- Sponsor
- R-Tech Ueno
- Start
- Apr 2013
- Primary completion
- Jul 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant human serum albumin in dry eye syndrome (DED), sponsored by R-Tech Ueno. Started Apr 2013; status: completed.
02
Drugs
recombinant human serum albumin
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT01843894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01843894.